Abstract
This research is part of a Young Investigator Award that aims at exploring public-private partnerships for drug development. The student will analyze the experience of the United States and European Union with the Critical Path and Innovative Medicines Initiative. This study will complement the analysis of Brazil`s case. The following aspects will be explored, but are not limited to these…